Nexus Pharmaceuticals
PrivateLast Round
Debt
May 1, 2020
Total Funding Raised
$1.72M
Company Overview
Nexus Pharmaceuticals operates in Healthcare & Life Sciences and is based in Lincolnshire, Illinois. Its latest recorded funding round was a Debt round in May 2020.
Nexus Pharmaceuticals is a healthcare company that specializes in the development and manufacturing of difficult-to-manufacture specialty and generic injectable drugs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Pharma Supply Chain, Smart Manufacturing
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nexus Pharmaceuticals Comparables
Compare Nexus Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sagent Pharmaceuticals | 92% | |
| Nevakar Pharmaceuticals, Inc. | 83% | |
| Nanjing King-friend Biochemical Pharmaceutical Co Ltd | 81% |
For institutional investors. Book with your work email.
Nexus Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | May 1, 2020 | ||||
| Grant | Jul 10, 2019 | ||||
| Grant | Jul 1, 2019 |
For institutional investors. Book with your work email.
Nexus Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Wisconsin Economic Development Corporation | Grant |
| JPMorgan Chase & Co. | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 1, 2020
$1.22M debt round from J.P. Morgan.
- Jul 10, 2019
$1.5M grant awarded by Wisconsin Economic Development Corporation.
For institutional investors. Book with your work email.
Nexus Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nexus Pharmaceuticals's valuation, stock price, and market status.
Is Nexus Pharmaceuticals a public or private company?
Nexus Pharmaceuticals is a private company.
What is the current stock price of Nexus Pharmaceuticals?
Nexus Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks Nexus Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nexus Pharmaceuticals worth (valuation)?
Valuation information for Nexus Pharmaceuticals is not publicly available.
Can I buy Nexus Pharmaceuticals stock?
Nexus Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nexus Pharmaceuticals's last funding round?
Nexus Pharmaceuticals's most recent funding round was Debt on May 1, 2020.
Who are the main investors in Nexus Pharmaceuticals?
Key investors in Nexus Pharmaceuticals include Wisconsin Economic Development Corporation, JPMorgan Chase & Co..
Will Nexus Pharmaceuticals IPO soon?
No public IPO plans have been announced for Nexus Pharmaceuticals.
How can I track Nexus Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in Nexus Pharmaceuticals's shares on secondary markets.